Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.87
$0.01991.08%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 309.52% | 47.50% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 309.52% | 47.50% | -- | -- | -- |
| Cost of Revenue | 1,490.91% | 438.46% | -- | -- | -- |
| Gross Profit | 59.62% | -140.74% | -- | -- | -- |
| SG&A Expenses | -4.16% | -1.58% | 26.50% | -48.19% | 62.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.17% | 15.26% | -23.16% | -28.02% | 26.66% |
| Operating Income | 25.33% | -14.47% | 25.27% | 30.00% | -22.44% |
| Income Before Tax | 26.40% | -15.17% | 4.44% | 29.76% | -22.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.40% | -15.17% | 4.44% | 29.76% | -22.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.40% | -15.17% | 4.44% | 29.76% | -22.14% |
| EBIT | 25.33% | -14.47% | 25.27% | 30.00% | -22.44% |
| EBITDA | 25.19% | -14.83% | 25.15% | 29.91% | -23.02% |
| EPS Basic | 35.62% | -6.53% | 7.50% | 40.20% | 2.24% |
| Normalized Basic EPS | 35.65% | -6.46% | 26.08% | 38.51% | -3.28% |
| EPS Diluted | 35.62% | -6.53% | 7.50% | 40.20% | 2.24% |
| Normalized Diluted EPS | 35.65% | -6.46% | 26.08% | 38.51% | -3.28% |
| Average Basic Shares Outstanding | 14.33% | 8.18% | 3.43% | 14.27% | 18.24% |
| Average Diluted Shares Outstanding | 14.33% | 8.18% | 3.43% | 14.27% | 18.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |